<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02984046</url>
  </required_header>
  <id_info>
    <org_study_id>CHU-0294</org_study_id>
    <secondary_id>2015-A01587-42</secondary_id>
    <nct_id>NCT02984046</nct_id>
  </id_info>
  <brief_title>Acute Bronchiolitis and Severity Markers: Interest in Protein CC16</brief_title>
  <acronym>CC16</acronym>
  <official_title>Acute Bronchiolitis and Severity Markers: Interest in Protein CC16</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Clermont-Ferrand</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Clermont-Ferrand</source>
  <brief_summary>
    <textblock>
      Acute bronchiolitis is a common viral infection in infants mainly due to RSV and rhinovirus.

      Biomarkers can be useful for predicting its severity. The serum CC16 is a marker of
      epithelial aggression. Its rate increase during RSV bronchiolitis in infants less than 7
      months. It could be an early predictive biomarker of the severity of acute bronchiolitis, and
      secondarily for the development of asthma.

      Two other markers of airway aggression seem to increase during acute bronchiolitis: serum
      SP-D protein and serum soluble receptor sRAGE.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Prospective, monocentric, case-control and study Primary end-point: correlation between serum
      CC16 level and severity of the bronchiolitis, evaluated by a clinical scoring system
      established at the time of the admission in Paediatric Emergency Unit. Secondary end-points:
      correlation with urinary CC16; correlation with risk factors for bronchial epithelial
      aggression, viruses, immediate morbidity and mortality. Study of serum SP-D and sRAGE levels.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>November 2015</start_date>
  <completion_date type="Anticipated">January 2019</completion_date>
  <primary_completion_date type="Anticipated">August 2018</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Serum CC16 rate</measure>
    <time_frame>at day 1</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Urinary CC16 rate</measure>
    <time_frame>at day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>SP-D rates</measure>
    <time_frame>at day 1</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sRAGE rates</measure>
    <time_frame>at day 1</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Acute Bronchiolitis</condition>
  <arm_group>
    <arm_group_label>acute bronchiolitis</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Prospective, monocentric, case-control and study Primary end-point: correlation between serum CC16 level and severity of the bronchiolitis, evaluated by a clinical scoring system</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Protein CC16</intervention_name>
    <arm_group_label>acute bronchiolitis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Infants under 1 year old hospitalized for acute bronchiolitis

        Exclusion Criteria:

          -  Broncho dysplasia

          -  Preterm under 34 weeks

          -  Cystic fibrosis

          -  Immune deficiency

          -  Suspicion of primary ciliary dyskinesia

          -  Congenital heart disease

          -  Acute renal failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>1 Year</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>André LABBE</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Clermont-Ferrand</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Patrick LACARIN</last_name>
    <phone>0473751195</phone>
    <email>placarin@chu-clermontferrand.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>CHU Clermont-Ferrand</name>
      <address>
        <city>Clermont-Ferrand</city>
        <zip>63003</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Patrick LACARIN</last_name>
      <phone>0473751195</phone>
      <email>placarin@chu-clermontferrand.fr</email>
    </contact>
    <investigator>
      <last_name>André LABBE</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>December 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>November 28, 2016</study_first_submitted>
  <study_first_submitted_qc>December 2, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 6, 2016</study_first_posted>
  <last_update_submitted>December 2, 2016</last_update_submitted>
  <last_update_submitted_qc>December 2, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 6, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Acute bronchiolitis</keyword>
  <keyword>RSV</keyword>
  <keyword>CC16</keyword>
  <keyword>SP-D</keyword>
  <keyword>sRAGE</keyword>
  <keyword>Severity</keyword>
  <keyword>Biomarkers</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bronchiolitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

